PureCycle Technologies is commercializing a patented, solvent-based purification process originally developed by Procter & Gamble to convert waste polypropylene into "ultra-pure" recycled resin sold under the PureFive brand. The company's flagship facility in Ironton, Ohio is designed to produce recycled resin with near-virgin characteristics for use in packaging, caps, closures, and other consumer applications, with a second facility in Rayong, Thailand in development.
PureCycle targets a fast-growing market for recycled-content plastics driven by consumer-brand sustainability commitments and evolving recycled-content regulations. Because the company is still scaling its first commercial plant and has not yet reached profitability, investors follow PCT primarily as a speculative play on plastic circularity and the pace at which the Ironton facility converts production into branded, high-margin sales. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the last 30 days, PCT declined approximately 41%, moving from a closing price near $2.77 to around $1.63. The decline was not gradual; a large portion occurred in a single session after the company reported third-quarter results on November 4, 2026, when shares fell roughly 38% the following day.
The quarterly picture is more severe. Over the trailing three months, PCT fell roughly 76%, from about $6.75 to about $1.63. This extended slide reflects a combination of slower-than-expected commercial ramp, recurring operational setbacks, and regulatory timing changes that have pushed expected demand further out.
The dominant catalyst was the third-quarter 2026 earnings release. Revenue came in at $2.35 million, down from $4.5 million in the second quarter, as two unplanned reliability issues at Ironton limited production and affected product quality, preventing shipments to branded customers. Management also disclosed that New Jersey had extended its food-contact exemption from 2027 to 2030, removing roughly 50 million pounds of expected annual volume from the near-term outlook and delaying about 15 programs.
The company acknowledged it no longer expects to reach its previously discussed 2026 exit-rate target, pushing back the timeline to breakeven. In response, Craig-Hallum cut its price target to $3 from $8, and multiple shareholder-rights firms initiated investigations into potential securities claims. These headwinds outweighed more constructive developments, including a three-year feedstock agreement with Waste Management for up to 25 million pounds annually, P&G products reaching store shelves, and the appointment of Fernando Musa as Executive Chairman.
The quarterly decline reflects a broader, multi-month narrative of slower commercial execution and persistent capital needs. Throughout 2026, PureCycle has continued to operate Ironton well below its design capacity while managing a first-of-its-kind purification process. The company's auditor raised going-concern considerations in its February 2026 annual filing, and a $395 million capital raise in June 2026 introduced meaningful dilution and renewed investor concerns about cash burn.
Regulatory timing risk has compounded the operational challenges. The New Jersey food-contact extension, announced in early September, pushed a large portion of anticipated demand into 2027 and later. While management has pivoted toward non-food applications and reported early commercial conversions, the market has continued to re-rate the stock lower as the path to sustained profitability remains dependent on ramping branded sales before liquidity is exhausted.
Investors will be watching whether Ironton sustains targeted on-stream reliability and converts its pipeline into branded purchase orders, particularly the expected fourth-quarter shipments to a large global cosmetics customer and railcar deliveries already underway. The pace of cost reduction is another focal point, given monthly operations spending of $7.8 million and total liquidity of $193 million plus an undrawn $200 million revolving facility.
Other factors include the timing and terms of Thailand project financing close, the 2027 non-food compliance deadlines in New Jersey, and whether additional recycled-content mandates in California and other regions support demand. Capital structure and potential future dilution remain key risks, as does the possibility of further operational or regulatory setbacks. These considerations are forward-looking and subject to change. From what I see, monitoring these elements closely will be essential in the months ahead.
In my own research process, I frequently rely on Tickeron’s AI tools to cross-reference performance data and identify comparable opportunities across sectors. The platform’s automated signals and pattern recognition features help me stay objective when evaluating names like PCT amid volatile moves. For instance, reviewing the AI Daily Buy/Sell Signals page offers a quick way to see how similar small-cap industrials are behaving in real time.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where PCT declined for three days, in 304 of 350 cases, the price declined further within the following month. The odds of a continued downward trend are 87%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PCT as a result. In 71 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
The Aroon Indicator for PCT entered a downward trend on November 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for PCT's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for PCT just turned positive on November 18, 2026. Looking at past instances where PCT's MACD turned positive, the stock continued to rise in 33 of 40 cases over the following month. The odds of a continued upward trend are 82%.
Following a +8.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where PCT advanced for three days, in 194 of 237 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
PCT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. PCT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (21.578) is normal, around the industry mean (10.189). P/E Ratio (-1.243) is within average values for comparable stocks, (-16.372). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.975). Dividend Yield (0.000) settles around the average of (0.050) among similar stocks. P/S Ratio (72.993) is also within normal values, averaging (251.106).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry IndustrialSpecialties